Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model

被引:180
作者
Thakker, M
Park, JS
Carey, V
Lee, JC
机构
[1] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1128/IAI.66.11.5183-5189.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Controversy persists over the role that the capsular polysaccharide plays in the pathogenesis of Staphylococcus aureus infections. To address this issue, we compared the mouse virulence of S. aureus Reynolds and capsule-defective mutant strains cultivated under conditions of high or low capsule expression. Strain Reynolds cells cultivated on Columbia salt agar plates expressed similar to 100-fold more type 5 capsular polysaccharide than did cells cultivated in Columbia salt broth. The relative virulence of strain Reynolds and its capsule-defective mutants after growth on either solid or liquid medium was examined in mice challenged intraperitoneally or intravenously. The results indicated that agar-grown Reynolds cells were cleared from the bloodstream of mice less readily than broth-grown Reynolds cells. When the parental and mutant strains were cultivated on solid medium, strain Reynolds sustained a higher level of bacteremia than did the capsular mutants. We performed in vitro opsonophagocytic killing assays to determine whether staphylococcal virulence for mice correlated with resistance to phagocytosis, S. aureus Reynolds cultivated on solid medium was susceptible to phagocytic killing only in the presence of specific capsular antibodies and complement. Strain Reynolds grown in broth showed opsonic requirements for phagocytic killing that were similar to those of the capsular mutants (grown in broth or on agar); i.e., the bacteria were opsonized for phagocytosis by nonimmune serum with complement activity. These studies indicate that optimal expression of capsule enhances bacterial virulence in the mouse model of bacteremia, probably by rendering the organisms resistant to opsonophagocytic killing by leukocytes.
引用
收藏
页码:5183 / 5189
页数:7
相关论文
共 29 条
[1]  
ADLAM C, 1983, STAPHLOCOCCI STAPHYL, P357
[2]   STAPHYLOCOCCUS-AUREUS CAPSULAR TYPES AND ANTIBODY-RESPONSE TO LUNG INFECTION IN PATIENTS WITH CYSTIC-FIBROSIS [J].
ALBUS, A ;
FOURNIER, JM ;
WOLZ, C ;
BOUTONNIER, A ;
RANKE, M ;
HOIBY, N ;
HOCHKEPPEL, H ;
DORING, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (12) :2505-2509
[3]  
ALHUS A, 1991, INFECT IMMUN, V59, P1008
[4]   PREDOMINANCE OF 2 NEWLY DESCRIBED CAPSULAR POLYSACCHARIDE TYPES AMONG CLINICAL ISOLATES OF STAPHYLOCOCCUS-AUREUS [J].
ARBEIT, RD ;
KARAKAWA, WW ;
VANN, WF ;
ROBBINS, JB .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1984, 2 (02) :85-91
[5]   STAPHYLOCOCCUS-AUREUS MICROCAPSULE EXPRESSION ATTENUATES BACTERIAL VIRULENCE IN A RAT MODEL OF EXPERIMENTAL ENDOCARDITIS [J].
BADDOUR, LM ;
LOWRANCE, C ;
ALBUS, A ;
LOWRANCE, JH ;
ANDERSON, SK ;
LEE, JC .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) :749-753
[6]   VARIATION IN THE EXPRESSION OF CELL-WALL PROTEINS OF STAPHYLOCOCCUS-AUREUS GROWN ON SOLID AND LIQUID-MEDIA [J].
CHEUNG, AL ;
FISCHETTI, VA .
INFECTION AND IMMUNITY, 1988, 56 (05) :1061-1065
[7]   DIAGNOSING STAPHYLOCOCCUS-AUREUS ENDOCARDITIS BY DETECTING ANTIBODIES AGAINST S-AUREUS CAPSULAR POLYSACCHARIDE TYPE-5 AND TYPE-8 [J].
CHRISTENSSON, B ;
BOUTONNIER, A ;
RYDING, U ;
FOURNIER, JM .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03) :530-533
[8]   PRODUCTION OF TYPE-5 CAPSULAR POLYSACCHARIDE BY STAPHYLOCOCCUS-AUREUS GROWN IN A SEMISYNTHETIC MEDIUM [J].
DASSY, B ;
STRINGFELLOW, WT ;
LIEB, M ;
FOURNIER, JM .
JOURNAL OF GENERAL MICROBIOLOGY, 1991, 137 :1155-1162
[9]   LABORATORY AND CLINICAL-EVALUATION OF CONJUGATE VACCINES COMPOSED OF STAPHYLOCOCCUS-AUREUS TYPE-5 AND TYPE-8 CAPSULAR POLYSACCHARIDES BOUND TO PSEUDOMONAS-AERUGINOSA RECOMBINANT EXOPROTEIN-A [J].
FATTOM, A ;
SCHNEERSON, R ;
WATSON, DC ;
KARAKAWA, WW ;
FITZGERALD, D ;
PASTAN, I ;
LI, XR ;
SHILOACH, J ;
BRYLA, DA ;
ROBBINS, JB .
INFECTION AND IMMUNITY, 1993, 61 (03) :1023-1032
[10]   A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge [J].
Fattom, AI ;
Sarwar, J ;
Ortiz, A ;
Naso, R .
INFECTION AND IMMUNITY, 1996, 64 (05) :1659-1665